Interactions of ceftobiprole with beta-lactamases from molecular classes A to D
- PMID: 17591851
- PMCID: PMC2043179
- DOI: 10.1128/AAC.00218-07
Interactions of ceftobiprole with beta-lactamases from molecular classes A to D
Abstract
The interactions of ceftobiprole with purified beta-lactamases from molecular classes A, B, C, and D were determined and compared with those of benzylpenicillin, cephaloridine, cefepime, and ceftazidime. Enzymes were selected from functional groups 1, 2a, 2b, 2be, 2d, 2e, and 3 to represent beta-lactamases from organisms within the antibacterial spectrum of ceftobiprole. Ceftobiprole was refractory to hydrolysis by the common staphylococcal PC1 beta-lactamase, the class A TEM-1 beta-lactamase, and the class C AmpC beta-lactamase but was labile to hydrolysis by class B, class D, and class A extended-spectrum beta-lactamases. Cefepime and ceftazidime followed similar patterns. In most cases, the hydrolytic stability of a substrate correlated with the MIC for the producing organism. Ceftobiprole and cefepime generally had lower MICs than ceftazidime for AmpC-producing organisms, particularly AmpC-overexpressing Enterobacter cloacae organisms. However, all three cephalosporins were hydrolyzed very slowly by AmpC cephalosporinases, suggesting that factors other than beta-lactamase stability contribute to lower ceftobiprole and cefepime MICs against many members of the family Enterobacteriaceae.
Similar articles
-
In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.Clin Microbiol Infect. 2007 Jun;13 Suppl 2:17-24. doi: 10.1111/j.1469-0691.2007.01722.x. Clin Microbiol Infect. 2007. PMID: 17488372 Review.
-
Genetic characterization of an extended-spectrum AmpC cephalosporinase with hydrolysing activity against fourth-generation cephalosporins in a clinical isolate of Enterobacter aerogenes selected in vivo.J Antimicrob Chemother. 2012 Jan;67(1):64-8. doi: 10.1093/jac/dkr423. Epub 2011 Oct 16. J Antimicrob Chemother. 2012. PMID: 22001269
-
[Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].Acta Med Croatica. 2004;58(4):307-12. Acta Med Croatica. 2004. PMID: 15700687 Croatian.
-
Interactions of beta-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral beta-lactams.Antimicrob Agents Chemother. 1998 May;42(5):1168-75. doi: 10.1128/AAC.42.5.1168. Antimicrob Agents Chemother. 1998. PMID: 9593145 Free PMC article.
-
[Behavior of ceftazidime in regard to different classes of beta-lactamases. The situation in 1988].Presse Med. 1988 Oct 26;17(37):1890-4. Presse Med. 1988. PMID: 2973579 Review. French.
Cited by
-
Bibliometric insights into the most influential papers on antibiotic adjuvants: a comprehensive analysis.Front Pharmacol. 2023 Nov 13;14:1276018. doi: 10.3389/fphar.2023.1276018. eCollection 2023. Front Pharmacol. 2023. PMID: 38027012 Free PMC article.
-
New antibiotics for bad bugs: where are we?Ann Clin Microbiol Antimicrob. 2013 Aug 28;12:22. doi: 10.1186/1476-0711-12-22. Ann Clin Microbiol Antimicrob. 2013. PMID: 23984642 Free PMC article. Review.
-
Efficacy of ceftobiprole Medocaril against Enterococcus faecalis in a murine urinary tract infection model.Antimicrob Agents Chemother. 2012 Jun;56(6):3457-60. doi: 10.1128/AAC.06102-11. Epub 2012 Mar 26. Antimicrob Agents Chemother. 2012. PMID: 22450988 Free PMC article.
-
Resistance and the management of complicated skin and skin structure infections: the role of ceftobiprole.Ther Clin Risk Manag. 2010 Oct 5;6:485-95. doi: 10.2147/TCRM.S5823. Ther Clin Risk Manag. 2010. PMID: 20957140 Free PMC article.
-
Ceftobiprole for the treatment of pneumonia: a European perspective.Drug Des Devel Ther. 2015 Aug 18;9:4565-72. doi: 10.2147/DDDT.S56616. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26316697 Free PMC article. Review.
References
-
- Bradford, P. A., S. Bratu, C. Urban, M. Visalli, N. Mariano, D. Landman, J. J. Rahal, S. Brooks, S. Cebular, and J. Quale. 2004. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City. Clin. Infect. Dis. 39:55-60. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Chemical Information
Medical
Research Materials
Miscellaneous